Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective and Randomized Analysis of Endoscopic Prostate Enucleation Using Moses 2.0 Technology Versus the New Thulium Fiber Laser in Medium and Large Prostates.

NCT06565741 is registered in ClinicalTrials.gov with Fundacio Puigvert as lead sponsor.

NCT NCT06565741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06565741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective and Randomized Analysis of Endoscopic Prostate Enucleation Using Moses 2.0 Technology Versus the New Thulium Fiber Laser in Medium and Large Prostates.
Lead sponsor
Fundacio Puigvert
Phase
Not applicable
Overall status
Recruiting
Start date
September 3, 2024
Completion date
September 30, 2028
Enrollment
120 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

endoscopic anatomical enucleation of the prostate (eeap), prostatic hyperplasia, surgery